Uterine myomas are benign, hormone-sensitive, fibromuscular tumors that diagnosed in about 25%-40% of women during their reproductive age. Uterine myomas may be asymptomatic or they can cause abnormal uterine bleeding, pelvic pain, pressure complaints, pregnancy-related complications and infertility. The management of women with uterine myomas remains controversial. Various treatment protocols use medical treatment (GnRH analogues), radiological intervention (uterine artery embolization, focused ultrasound surgery) or surgical intervention (myomectomy, hysterectomy). Recent advances in the nonsurgical management of uterine myomas have shown promising results simplifying or eliminating the need for surgical intervention
Last date updated on September, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi